Candid Health
Conquer RCM complexity. Forever.
Overview
Candid Health has raised $120M in a Series D round on Jul 22, 2026, with participation from Sixth Street. The company conquer RCM complexity. Forever.. The round will be used to accelerate product development, expand the team, and scale go-to-market operations.
Operating in the hospitals and health care sector, Candid Health is positioned to capitalize on growing demand for innovative solutions in this space. With fresh capital, the company is expected to invest heavily in R&D and talent acquisition, signaling a period of aggressive growth ahead.
Market Outlook
With $120M now on the balance sheet, Candid Health enters a new phase of growth that typically involves rapid hiring, technology upgrades, and vendor evaluations. For sales professionals and service providers, this represents a prime opportunity to engage while budget allocation decisions are being made and the team is actively building out its operational infrastructure.
Why contact Candid Health now
With $120M in fresh capital from Series D, Candid Health is entering a rapid growth phase. Post-funding startups typically increase headcount by 30-50% and begin evaluating new tools and services immediately. The founders and decision-makers are actively taking meetings right now — making this the perfect time to connect before their calendars fill up.
Founders & Contacts
Investors
Company Facts
| Company | Candid Health |
| Amount Raised | $120M |
| Funding Round | Series D |
| Date Raised | Jul 22, 2026 |
| Founded | 2019 |
| Industry | Hospitals and Health Care |
| Founders |
Get Verified Founder Emails
Access verified email addresses and contact details for Candid Health's founders and thousands of other funded startups.
Start Free Trial